Funding for this research was provided by:
National Natural Science Foundation of China (31620103910, 81874181, 91440203, 81772512, 31601021)
the Emerging Frontier Program of Hospital Development Center (SHDC12018107)
the General Surgery Construction Program of Shanghai Municipal Health Commission (2017ZZ02011)
Xinhua Hospital PI-startup funds (JZPI201716)
the Project of Excellent Young Scholars from Shanghai Municipal Health and Family Planning Commission (2018YQ10)
the Talent Development Fund from Shanghai Municipal Human Resources and Social Security Bureau (2018048)
Shanghai Pujiang Program (17PJ1406100)
Shanghai Key Laboratory of Biliary Tract Disease Research Foundation (17DZ2260200)
Text and Data Mining valid from 2019-11-21
Received: 24 June 2019
Accepted: 4 November 2019
First Online: 21 November 2019
Ethics approval and consent to participate
: Written informed consent was obtained from all GBC patients. This study was approved by the ethics committee of Xinhua hospital. All the animal experiments were conducted strictly according to the Guide for the Care and Use of Laboratory Animals, and approved by the Animal Care and Use Committee of the Xinhua Hospital.
: All subjects have written informed consent.
: The authors declare that they have no competing interests.